Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kay See Tan

Showing results (141-150 of 214) with videos related to

Pageof 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks AnalysisTakashi Eguchi, Sarina Bains, Ming-Ching Lee, et al.
NPJ Precision Oncology|July 22, 2021
Preoperative clinical and tumor genomic features associated with pathologic lymph node metastasis in clinical stage I and II lung adenocarcinomaRaul Caso, James G Connolly, Jian Zhou, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 27, 2024
Characterizing a learning curve for robotic-assisted bronchoscopy: Analysis of skills acquisition in a high-volume academic centerMatthew J Bott, Nicolas Toumbacaris, Kay See Tan, et al.
The Annals of Thoracic Surgery|March 19, 2018
Safety and Feasibility of Lung Resection After Immunotherapy for Metastatic or Unresectable TumorsMatthew J Bott, Jonathan Cools-Lartigue, Kay See Tan, et al.
Oncotarget|May 7, 2016
Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinomaTakashi Eguchi, Kyuichi Kadota, Jamie Chaft, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2025
Correlation of Histologic Features with Gene Alterations in Pleural MesotheliomaRachel E Fanaroff, Soo-Ryum Yang, Kay See Tan, et al.
Anesthesiology|March 9, 2022
Amiodarone with or without N-Acetylcysteine for the Prevention of Atrial Fibrillation after Thoracic Surgery: A Double-blind, Randomized TrialDavid Amar, Hao Zhang, Mina K Chung, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 2024
Late recurrence of completely resected stage I to IIIA lung adenocarcinomaCameron N Fick, Elizabeth G Dunne, Nicolas Toumbacaris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessmentAngela DeMichele, Amy S Clark, Kay See Tan, et al.
Molecular Cell|July 18, 2025
The SWI/SNF-related protein SMARCA3 is a histone H3K23 ubiquitin ligase that regulates H3K9me3 in cancerIfé Akano, Jakob M Hebert, Rochelle L Tiedemann, et al.
Pageof 22

Showing results (141-150 of 214) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Impact of Increasing Age on Cause-Specific Mortality and Morbidity in Patients With Stage I Non-Small-Cell Lung Cancer: A Competing Risks AnalysisTakashi Eguchi, Sarina Bains, Ming-Ching Lee, et al.
NPJ Precision Oncology|July 22, 2021
Preoperative clinical and tumor genomic features associated with pathologic lymph node metastasis in clinical stage I and II lung adenocarcinomaRaul Caso, James G Connolly, Jian Zhou, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 27, 2024
Characterizing a learning curve for robotic-assisted bronchoscopy: Analysis of skills acquisition in a high-volume academic centerMatthew J Bott, Nicolas Toumbacaris, Kay See Tan, et al.
The Annals of Thoracic Surgery|March 19, 2018
Safety and Feasibility of Lung Resection After Immunotherapy for Metastatic or Unresectable TumorsMatthew J Bott, Jonathan Cools-Lartigue, Kay See Tan, et al.
Oncotarget|May 7, 2016
Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinomaTakashi Eguchi, Kyuichi Kadota, Jamie Chaft, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 9, 2025
Correlation of Histologic Features with Gene Alterations in Pleural MesotheliomaRachel E Fanaroff, Soo-Ryum Yang, Kay See Tan, et al.
Anesthesiology|March 9, 2022
Amiodarone with or without N-Acetylcysteine for the Prevention of Atrial Fibrillation after Thoracic Surgery: A Double-blind, Randomized TrialDavid Amar, Hao Zhang, Mina K Chung, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 1, 2024
Late recurrence of completely resected stage I to IIIA lung adenocarcinomaCameron N Fick, Elizabeth G Dunne, Nicolas Toumbacaris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessmentAngela DeMichele, Amy S Clark, Kay See Tan, et al.
Molecular Cell|July 18, 2025
The SWI/SNF-related protein SMARCA3 is a histone H3K23 ubiquitin ligase that regulates H3K9me3 in cancerIfé Akano, Jakob M Hebert, Rochelle L Tiedemann, et al.
Pageof 22